Folate conjugates of albumin-binding entities

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9295739
APP PUB NO 20140234216A1
SERIAL NO

14238954

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention is directed towards new trifunctional folate-conjugates comprising a folate, an albumin binder and a radionuclide-based therapeutic or diagnostic moiety as well as pharmaceutical compositions thereof, their method of production and their use in diagnostic and therapeutic medical applications, such as diagnostic nuclear imaging and radionuclide therapy.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MERCK & CIE8200 SCHAFFHAUSEN

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ametamey, Simon Mensah Zurich, CH 13 31
Fischer, Cindy Ramona Zurich, CH 3 13
Groehn, Viola Dachsen, CH 51 182
Moser, Rudolf Schaffhausen, CH 64 360
Muller, Cristina Magdalena Nussbaumen, CH 6 14
Schibli, Roger Baden, CH 40 236
Struthers, Harriet Basel, CH 1 8

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 29, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00